FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,096 letters match. Newest first.

  1. Sen Up Huat Seafood Trading Sdn Bhd

    FDA warns Malaysian seafood processor Sen Up Huat over inadequate histamine controls in its seafood safety plan for bonito and other fish.

    High risk
  2. Nobles Medical Technology II, Inc.

    FDA warns Nobles Medical Technology II over oversight failures in NobleStitch EL clinical study.

    High risk
  3. Dream Wholesale, Inc

    Dream Wholesale, an importer of frozen spinach and chickpeas, lacked required Foreign Supplier Verification Program (FSVP) checks.

    High risk
  4. Bell International Laboratories, Inc.

    Bell International Laboratories, an OTC drugmaker, was cited for manufacturing rule violations including missing glycerin DEG/EG testing and inadequate quality oversight.

    High risk
  5. Trang Thuy Seafood Co., LTD

    FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.

    High risk
  6. Amman Pharmaceutical Industries

    FDA warned Amman Pharmaceutical Industries after a 2023 inspection found sterile drug manufacturing and data integrity failures.

    High risk
  7. Empacadora Bilbo S.A. DBA Bilbosa

    FDA warns Ecuadorian seafood processor Bilbosa over seafood safety plan gaps for histamine and C. botulinum.

    High risk
  8. Sichuan Deebio Pharmaceutical Co. Ltd.

    FDA warns Sichuan Deebio Pharmaceutical over API manufacturing and data-integrity failures.

    High risk
  9. Ningbo Poplar Daily-Use

    FDA warned Ningbo Poplar Daily-Use that its OTC drugs had manufacturing quality failures in testing, component identity checks, and stability data.

    High risk
  10. Barkey GmbH & Co. KG

    FDA warns Barkey over unapproved plasmatherm V blood thawing device and missing design risk analysis.

    High risk
  11. QuVa Pharma, Inc.

    FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.

    High risk
  12. Lucky K.T. Co., Inc.

    FDA warns Lucky K.T. noodle maker over insanitary conditions, missing food safety plan, undeclared wheat.

    High risk
  13. Curtis Jacquot dba Pacific BioLogic Co.

    Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.

    High risk
  14. Iowa Egg Company Inc.

    Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.

    High risk
  15. Indian Groceries and Spices, Inc.

    FDA says Indian Groceries and Spices lacked required foreign supplier checks for imported cumin, chili powder, and mung beans.

    Medium
  16. Battle Creek Co-op/CHS, LLC dba Progressive Nutrition

    Progressive Nutrition's cattle feed contained excess urea linked to 17 cattle deaths, with preventive-control and medicated-feed violations.

    High risk
  17. Les Importations Herbasanté Inc.

    Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.

    High risk
  18. Inmar Supply Chain Solutions, LLC

    FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.

    High risk
  19. Nantong Furuida Packaging Products Co., Ltd.

    Nantong Furuida, an over-the-counter drug manufacturer, failed required manufacturing controls and methanol checks, leading to an FDA import alert.

    High risk
  20. S & J International Enterprises Public Company Limited

    FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.

    High risk
  21. Mexpobaja Corporation

    Oakland, California importer Mexpobaja had no FSVP for its fresh produce and never verified suppliers' Produce Safety Rule compliance.

    High risk
  22. Grace Supply Inc.

    Grace Supply lacked required foreign supplier verification for most imported foods and adequate Salmonella verification for shredded coconut.

    High risk
  23. A True Move LLC

    FDA warns Houston importer A True Move for lacking FSVP plans for imported banana sodas, lollipops, and tomato paste.

    Medium
  24. JJR Global Inc.

    FDA warns JJR Global over missing FSVP for imported chutneys and other foods.

    Medium
  25. Marion Mullet Farm

    FDA warned Indiana calf dealer Marion Mullet Farm about medicated calves sold without treatment records or withdrawal compliance.

    High risk
  26. Martin Farm, Konrad Martin

    Nappanee dairy farm used enrofloxacin and ceftiofur in calves contrary to labeling and kept incomplete treatment records.

    High risk
  27. Cavevi Naturals LLC

    FDA warns Cavevi Naturals it imported candy and Cheetos without required foreign supplier food-safety verification.

    Medium
  28. Dr. Joel Kaplan Inc.

    FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.

    High risk
  29. Comercializadora Internacional Piscicola New Your S.A

    Colombian tilapia processor's HACCP plan omits Clostridium botulinum and drug-residue hazards, FDA says after remote assessment.

    High risk
  30. Woorilife & Health

    Woorilife & Health, a South Korean OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.

    High risk
  31. MiMedx Group, Inc.

    FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.

    High risk
  32. Deymed Diagnostic s.r.o.

    Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.

    Medium
  33. Kimera Labs, Inc.

    FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.

    High risk
  34. Inopak, Ltd.

    Inopak, Ltd. was warned of CGMP (current good manufacturing practice) violations after inspection: poor quality oversight of contract-made hand sanitizer and missing stability testing.

    High risk
  35. Wipro Unza Singapore Private, Limited

    FDA cites Wipro Unza Singapore for refusing OTC hand sanitizer records, leading to import alert.

    High risk
  36. Patcos Cosmetics Pvt. Ltd.

    Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.

    High risk
  37. Colonial Dames Company, Ltd

    FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.

    High risk
  38. Distribuidora Jocorena Inc.

    Distribuidora Jocorena lacked required foreign supplier checks for imported corn flour, frozen tamales, and beans, FDA says.

    Medium
  39. Sudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi

    FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.

    High risk
  40. Sonesta Medical AB

    FDA warned Sonesta Medical AB that its radiographic and cystometric tables violated device quality system rules.

    Medium
  41. Kyawkhin Inc.

    Kyawkhin Inc. had no foreign supplier verification program for imported chili paste, peanut snack, and beverage base.

    Medium
  42. Desserts by Helen, Inc.

    FDA cited Desserts by Helen for unsanitary conditions and cleaning failures at its Louisville ready-to-eat bakery.

    High risk
  43. Fresenius Medical Care AG & Co. KGaA

    FDA warns Fresenius over delayed fixes and reporting for PCB leaching from silicone tubing in hemodialysis machines.

    High risk
  44. Intas Pharmaceuticals Limited

    FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.

    High risk
  45. AmLion Toothpaste Mfg. Sdn. Bhd.

    FDA cites AmLion Toothpaste in Malaysia for CGMP failures, including no testing of glycerin and sorbitol for DEG/EG; firm stays on import alert.

    High risk
  46. Cipla Limited

    FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.

    High risk
  47. Cerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi

    FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.

    High risk
  48. Xiamen Wally Bath Manufacture Co., Ltd.

    FDA warns Xiamen Wally Bath over current good manufacturing practice failures for over-the-counter hand sanitizer, including raw material and release testing gaps.

    High risk
  49. Brenntag Great Lakes, LLC

    Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.

    High risk
  50. Wello Inc.

    FDA cited Wello Inc. for misbranded welloStationX devices because labels lacked unique device identifiers and required GUDID data were not submitted.

    Low